Immediate Impact
3 from Science/Nature 57 standout
Citing Papers
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Works of Adelaida Lamas being referenced
Inhaled antibiotics for the treatment of chronic bronchopulmonaryPseudomonas aeruginosainfection in cystic fibrosis: systematic review of randomised controlled trials
2013
Population Structure and Antimicrobial Susceptibility of Both Nonpersistent and Persistent Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Patients
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Adelaida Lamas | 256 | 171 | 99 | 24 | 526 | |
| Patrizia Morelli | 190 | 173 | 70 | 29 | 488 | |
| Alejandro Díaz | 73 | 94 | 120 | 55 | 572 | |
| Pasqualina Ferri | 187 | 143 | 48 | 16 | 523 | |
| Kazuyoshi MAEJIMA | 53 | 181 | 93 | 47 | 554 | |
| J. van der Laag | 307 | 61 | 49 | 22 | 495 | |
| Jan Verhaegen | 181 | 62 | 139 | 21 | 613 | |
| S.P. Conway | 266 | 113 | 131 | 27 | 613 | |
| Rachel V. Floyd | 71 | 248 | 108 | 18 | 532 | |
| Ingrid M. C. Kamerling | 138 | 108 | 77 | 41 | 632 | |
| Lucie Vettoretti | 218 | 91 | 123 | 14 | 483 |
All Works
Loading papers...